Large pharmaceutical companies say allowing Medicare to negotiate lower drug prices will stifle innovation in drug development. Read a new op-ed in Harvard Business Review to find out why that’s not so.

Area of Focus

Maps and Interactives

April 28, 2015

Why Do We Need Innovation in Health Care?

A Visual Explainer

Publication Details

Date

April 28, 2015

Area of Focus

Improving Health Care Quality

Topics

Delivery System Reform,
Technology and Health Care,
Health Information Technology,
Coverage and Access

Advanced Search

Advanced Search

Filter your query

Publication Types

Other

Why Do We Need Innovation in Health Care?

A Visual Explainer

Publication Types

Other

Why Do We Need Innovation in Health Care?

A Visual Explainer

Related Content

Medicare Advantage vs. Traditional Medicare: How Do Beneficiaries’ Characteristics and Experiences Differ?

Living Independently with GRACE

How Many COVID-19 Hospitalizations and Deaths Can Be Averted if States Immediately Accelerate Their Vaccination Efforts?